Teva Pharmaceutical Industries

Teva Pharmaceutical Industries Newswire

Comprehensive Real-Time News Feed for Teva Pharmaceutical Industries.

Results 1 - 20 of 549 in Teva Pharmaceutical Industries

  1. Recent Study: NuPathe Inc. (PATH) - Medical Equipment - Deals and Alliances ProfileRead the original story

    18 hrs ago | PR-inside.com

    ... the US. In Janauary 2014, the company entered into an agreement to be acquired by Teva Pharmaceutical Industries Ltd., for a purchase consideration of $3.65 per share. Full Report Details at - www.fastmr.com/p ...

    Comment?

  2. Antares Pharma to Present at the 26th Annual Piper Jaffray Healthcare ConferenceRead the original story

    18 hrs ago | Freshnews

    ... multi-use pen injectors and reusable needle-free injectors marketed as Tjet and Zomajet by Teva Pharmaceutical Industries, Ltd (Teva) and Ferring Pharmaceuticals (Ferring), respectively. Antares Pharma has a multi-product deal with Teva that ...

    Comment?

  3. Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2014 - New Study ReleasedRead the original story

    20 hrs ago | PR-inside.com

    ... Overview of Pfizer Inc. Immunomedics, Inc. Clinical Trial Overview of Immunomedics, Inc. Teva Pharmaceutical Industries Limited Clinical Trial Overview of Teva Pharmaceutical Industries Limited Immupharma Plc Clinical Trial Overview of Immupharma ...

    Comment?

  4. Japanese Legislation Takes Effect for Expedited Approvals of Regenerative Medical ProductsRead the original story

    Yesterday | GlobeNewswire

    ... low back pain, MPC-150-IM for chronic congestive heart failure, in partnership with Teva Pharmaceutical Industries Ltd., and MSC-100-IV for acute graft versus host disease (aGVHD). CONTACT: Julie Meldrum Global Head of Corporate Communications ...

    Comment?

  5. Hypertension - Pipeline Review, H2 2014 - New Report AvailableRead the original story

    Monday | PR-inside.com

    ... Corp., Daewoong Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Teva Pharmaceutical Industries Limited, Toray Industries, Inc., IntelGenx Corp., Medivir AB, Compugen Ltd., Palatin Technologies, Inc., Cytokinetics, Inc., Yungjin Pharm ...

    Comment?

  6. "Young Jewish Americans are less supportive of Israel"Read the original story w/Photo

    Monday | Jerusalem Post

    ... will speak on "Business opportunities for Israeli companies in Central and Eastern Europe; Teva Pharmaceutical Industries president and CEO Erez Vigodman ; and Intel Israel president and SVP Shmuel (Mooly) Eden. Your comment must be approved by a ...

    Comment?

  7. CEO of Israeli drug maker Teva out amid reported squabble with board, looming job cutsRead the original story w/Photo

    Oct 30, 2013 | Nanaimo Daily News

    Israeli drug manufacturer Teva Pharmaceuticals Ltd. announced Wednesday its CEO had resigned, following a public uproar over a contentious restructuring plan set to cut thousands of jobs worldwide. In a statement, Teva said its board of directors and President and CEO Jeremy Levin had agreed for him to step down.

    Comment?

  8. Relapsing Remitting Multiple Sclerosis (RRMS) - Pipeline Review, H2 2014 - New Market Research ReportRead the original story

    Saturday Nov 22 | PR-inside.com

    ... Inc., Novartis AG, Actelion Ltd, Mitsubishi Tanabe Pharma Corporation, Octapharma AG, Teva Pharmaceutical Industries Limited, Genmab A/S, Merck KGaA, Antisense Therapeutics Limited, Opexa Therapeutics, Inc., Trophos SA, Allozyne, Inc., Amarna ...

    Comment?

  9. Just Published: "Constipation - Pipeline Review, H2 2014"Read the original story

    Friday Nov 21 | PR-inside.com

    ... Sumitomo Dainippon Pharma Co., Ltd., Astellas Pharma Inc., Kissei Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Limited, Shire Plc, AlbireoPharma, Sanwa Kagaku Kenkyusho Co., Ltd., Sucampo Pharmaceuticals, Inc., Ironwood Pharmaceuticals, ...

    Comment?

  10. Biotech's 3 Most Influential CEOsRead the original story w/Photo

    Thursday Nov 20 | The Motley Fool

    Who's the most influential CEO in the biotech business? The answer to that question might be largely a matter of opinion; however, there are definite standouts in the sector -- three of whom receive an enthusiastic "thumbs-up" from these Motley Fool health care contributors. Todd Campbell : Phillip Frost gets my nod as the most influential CEO in biotech.

    Comment?

  11. Senate Health, Education, Labor & Pensions Committee to hold a hearingRead the original story

    Thursday Nov 6 | Theflyonthewall.com

    Senate Health, Education, Labor & Pensions Committee to hold a hearing The Subcommittee on Primary Health and Aging holds a hearing entitled, "Why Are Some Generic Drugs Skyrocketing In Price?" with President & CEO Vigodman of Teva Pharmaceutical and President & CEO Bedrosian of Lannett Company on November 20 at 1 pm. Webcast Link Teva patent victory over Warner Chilcott, Roche affirmed The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva in a patent dispute with Warner Chilcott and Roche over patents related to osteoporosis drug risedronate.

    Comment?

  12. Now Available: Cognitive Impairment - Pipeline Review, H2 2014Read the original story

    Thursday Nov 20 | PR-inside.com

    ... Roche Ltd., AstraZeneca PLC, Merck & Co., Inc., Panacea Pharmaceuticals, Inc., Pfizer Inc., Teva Pharmaceutical Industries Limited, Shire Plc, Evotec AG, Suven Life Sciences Ltd., AGY Therapeutics, Inc., Cardax Pharmaceuticals, Inc., Siena Biotech ...

    Comment?

  13. Recent Study: Global Organ Preservation Solutions Market 2014-2018Read the original story

    Thursday Nov 20 | PR-inside.com

    ... * CryoLife * Lifeline Scientific * Organ Recovery Systems * Preservation Solutions * Teva Pharmaceutical Industries * ToleroTech Market Driver * Increased Incidences of Organ Failure * For a full, detailed list, view our report Market Challenge * ...

    Comment?

  14. Justice Department, Senate investigating generic drug price hikesRead the original story w/Photo

    Wednesday Nov 19 | Philly.com

    ... from Aetna. Janczewski's annoyance increased when he learned that the drug's manufacturer, Teva Pharmaceutical Industries Ltd., had increased its profits on generics. Janczewski, 73, said this week he went to a neighborhood Rite Aid pharmacy and ...

    Comment?

  15. New Market Research Report: Binge Eating Disorder - Pipeline Review, H2 2014Read the original story

    Wednesday Nov 19 | PR-inside.com

    ... understanding the factors that drove them from pipeline Companies Mentioned in this Report: Teva Pharmaceutical Industries Limited, Shire Plc, Omeros Corporation, Heptares Therapeutics Ltd., Lightlake Therapeutics Inc. About Global Markets Direct ...

    Comment?

  16. New Report Available: Asthma - Pipeline Review, H2 2014Read the original story

    Wednesday Nov 19 | PR-inside.com

    ... a Corporation, Ono Pharmaceutical Co., Ltd., Orion Corp, Pfizer Inc., SK Chemicals Co., Ltd., Teva Pharmaceutical Industries Limited, Zambon Company S.p.A., OPKO Health, Inc., iCo Therapeutics Inc.,

    Comment?

  17. Teva Canada Announces the Launch of (Pr)Teva-Celecoxib, a generic of (Pr)Celebrex/Read the original story

    Monday Nov 17 | BioSpace

    Teva Canada Limited, a subsidiary of Teva Pharmaceutical Industries Ltd., announced today that Health Canada has approved its application for the generic version of PrCelebrexA for the symptomatic relief associated with osteoarthritis, rheumatoid arthritis and ankylosing spondylitis. PrTeva-Celecoxib is also indicated for the short-term management of moderate to severe acute pain in adults in conditions such as musculoskeletal and/or soft tissue trauma including sprains, postoperative orthopaedic, and pain following dental extraction.

    Comment?

  18. 's M&A Chatter for Tuesday November 18, 2014Read the original story w/Photo

    Tuesday Nov 18 | Benzinga

    ... on the buyout rumor and a strong earnings report and guidance. The Rumor : Shares of Teva Pharmaceutical Industries Limited (TEVA) (NYSE: TEVA ) rose Tuesday on unconfirmed market chatter of a potential bid by Valeant Pharmaceuticals International, ...

    Comment?

  19. Teva Pharmaceutical Industries Limited Launches Liquid Formulation Of ...Read the original story

    Monday Nov 17 | BioSpace

    Teva Pharmaceutical Industries Ltd., today announced the commercial availability of a liquid formulation of TREANDAA Injection. This new liquid formulation removes the step of reconstituting lyophilized powder with sterile water prior to adding the required dose of medicine to the infusion bag and administering to a patient.

    Comment?

  20. Teva patent victory over Warner Chilcott, Roche affirmedRead the original story

    Tuesday Nov 4 | Theflyonthewall.com

    Teva patent victory over Warner Chilcott, Roche affirmed The U.S. Court of Appeals for the Federal Circuit ruled that a district court was correct to grant summary judgment to Teva in a patent dispute with Warner Chilcott and Roche over patents related to osteoporosis drug risedronate. Teva calls active on renewed takeover chatter Teva November 57 and 58 calls are active on total call volume of 21K contracts following renewed takeover chatter.

    Comment?